Mabeza, Ronalyn M.

HRN: 24-15-92  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2024
CO-AMOXICLAV 625MG (TAB)
01/07/2024
01/13/2024
PO
1tab
BID
Rmle
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: